Australia - engelsk - Department of Health (Therapeutic Goods Administration)

global medical solutions australia pty limited t/a radpharm scientific - pentetic acid, quantity: 5 mg - injection, powder for - excipient ingredients: stannous chloride - indications as at 25 september 1996: technetium (99mtc) pentetate may be used as a renal perfusion imaging pharmaceutical.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - pentetic acid, quantity: 10 mg - injection, powder for - excipient ingredients: stannous chloride dihydrate; sodium chloride - 99mtc-pentastan may be used to perform kidney-imaging, brain imaging, to assess renal perfusion and estimate glomeruler filtration rate.

Irland - engelsk - HPRA (Health Products Regulatory Authority)

curium netherlands b.v. - pentetic acid - kit for radiopharmaceutical preparation - 20.8 milligram(s) - technetium (99mtc) pentetic acid; technetium (99mtc) pentetic acid

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - pentetic acid, quantity: 5 mg - injection, powder for - excipient ingredients: stannous chloride dihydrate; sodium chloride - 99mtc-pentastan may be used to perform kidney-imaging, brain imaging, to assess renal perfusion and to estimate glomeruler filtration rate.

USA - engelsk - NLM (National Library of Medicine)

jubilant draximage inc., dba jubilant radiopharma - pentetic acid (unii: 7a314hqm0i) (pentetic acid - unii:7a314hqm0i) - pentetic acid 20 mg - draximage® dtpa, after radiolabeling with technetium tc 99m, is indicated for brain imaging in adults by intravenous administration. renal visualization, assessment of renal perfusion, and estimation of glomerular filtration rate in adult and pediatric patients by intravenous administration. lung ventilation imaging and evaluation of pulmonary embolism when paired with perfusion imaging in adult and pediatric patients when administered by nebulizer for inhalation. hypersensitivity to the active ingredient or to any component of the product [see warnings and precautions (5.1)]. risk summary limited available data with technetium tc 99m pentetate use in pregnant women are insufficient to inform a drug associated risk for major birth defects and miscarriage. technetium tc 99m pentetate is transferred across the placenta (see data) . no animal reproductive studies have been conducted with technetium tc 99m pentetate. all radiopharmaceuticals have the potential to cause fetal harm depending on the fetal stage of

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

global medical solutions australia pty limited t/a radpharm scientific - medronic acid, quantity: 10 mg - injection, powder for - excipient ingredients: ascorbic acid; stannous chloride - indications as at 25 september 1996: technetium (99mtc) medronate may be used as a skeletal imaging pharmaceutical.

Irland - engelsk - HPRA (Health Products Regulatory Authority)

cis bio international - calcium trisodium pentetate - powder for solution for injection - 9.10 mg milligram - technetium (99mtc) compounds; technetium (99mtc) pentetic acid

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

curium netherlands b.v. - acide pentétique 20 - poudre - 20,8 mg - lyophilisée pour un flacon > acide pentétique 20,8 mg - produit radiopharmaceutique à usage diagnostique. - classe pharmacothérapeutique: médicament radiopharmaceutique à usage diagnostique pour le système rénal et l’appareil respiratoire, composés au technétium (99mtc).code atc : v09ca01 ; v09ea01ce médicament est à usage diagnostique uniquement.technescan dtpa est utilisé dans les examens scintigraphiques pour étudier : les reins le cerveau les poumons le reflux gastro- œsophagien et la vidange gastrique.ce médicament se présente sous forme d’une poudre non radioactive. lorsqu’il est mélangé avec une substance radioactive appelée pertechnétate (99mtc) de sodium, il forme du pentétate de technétium (99mtc). lorsqu’il est administré dans l’organisme, il s’accumule au niveau de certains organes tels que les reins ou le cerveau.la substance radioactive peut être photographiée (par scintigraphie) en dehors de l’organisme à l’aide de caméras spéciales. les images montrent la distribution de la radioactivité au sein de l’organe et de l’ensemble de l’organisme. elle fournit également au médecin de précieuses informations sur la structure et le fonctionnement de cet organe.l’utilisation de technescan dtpa entraîne une exposition à une faible quantité de radioactivité. votre médecin et le spécialiste de médecine nucléaire ont estimé que le bénéfice clinique que vous retirerez de l’examen avec ce produit radiopharmaceutique l’emportera sur le risque dû aux radiations.

Israel - engelsk - Ministry of Health

isorad ltd, israel - calcium trisodium pentetate - solution for injection - calcium trisodium pentetate 20 mg/vial - technetium (99mtc) pentetic acid - technetium (99mtc) pentetic acid - kidney, brain, aerosol imaging.

USA - engelsk - NLM (National Library of Medicine)

jubilant draximage (usa) inc. - technetium tc-99m sestamibi (unii: 971z4w1s09) (technetium tc-99m sestamibi - unii:971z4w1s09) - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate 1 mg in 1 ml - myocardial imaging: kit for the preparation of technetium tc 99m sestamibi injection is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. technetium tc 99m sestamibi evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agents labeling). it is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia. breast imaging: kit for the preparation of technetium tc 99m sestamibi injection is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpable breast mass. kit f